Search Results

NOD-IN-1 50 mg  | 99.43%

TargetMol

NOD-IN-1 is a potent mixed inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptors.

More Information Supplier Page

NOD-IN-1 10 mg  | 99.43%

TargetMol

NOD-IN-1 is a potent mixed inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptors.

More Information Supplier Page

Macozinone 5 mg  | 100.00%

TargetMol

Macozinone (PBTZ169) inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043.

More Information Supplier Page

Macozinone 50 mg  | 100.00%

TargetMol

Macozinone (PBTZ169) inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043.

More Information Supplier Page

Macozinone 25 mg  | 100.00%

TargetMol

Macozinone (PBTZ169) inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043.

More Information Supplier Page

NSC23005 Sodium 100 mg  | Purity Not Available

TargetMol

NSC23005 sodium is a novel and effective p18 inhibitor (ED50=5.21 nM) in promoting Hematopoietic stem cells (HSCs) expansion in both murine and human models.

More Information Supplier Page

NSC23005 Sodium 10 mg  | Purity Not Available

TargetMol

NSC23005 sodium is a novel and effective p18 inhibitor (ED50=5.21 nM) in promoting Hematopoietic stem cells (HSCs) expansion in both murine and human models.

More Information Supplier Page

U93631 5 mg  | Purity Not Available

TargetMol

GABAA receptor antagonist that binds the picrotoxin site and stabilizes the inactive form of the channel via allosteric interaction. Accelerates the decay of GABA-induced Cl- currents with little effect on peak amplitude. Also inhibits 5-HT3A receptors via a similar mechanism.

More Information Supplier Page